Intuitive Surgical/$ISRG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Intuitive Surgical
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.
Ticker
$ISRG
Sector
Primary listing
Employees
15,638
Headquarters
Website
ISRG Metrics
BasicAdvanced
$189B
70.69
$7.56
1.61
-
Price and volume
Market cap
$189B
Beta
1.61
52-week high
$616.00
52-week low
$425.00
Average daily volume
2.6M
Financial strength
Current ratio
6.597
Quick ratio
3.49
Profitability
EBITDA (TTM)
3,411.9
Gross margin (TTM)
66.38%
Net profit margin (TTM)
28.58%
Operating margin (TTM)
29.52%
Effective tax rate (TTM)
12.65%
Revenue per employee (TTM)
$610,000
Management effectiveness
Return on assets (TTM)
9.56%
Return on equity (TTM)
16.90%
Valuation
Price to earnings (TTM)
70.69
Price to revenue (TTM)
19.856
Price to book
11.18
Price to tangible book (TTM)
11.41
Price to free cash flow (TTM)
84.03
Free cash flow yield (TTM)
1.19%
Free cash flow per share (TTM)
6.358
Growth
Revenue change (TTM)
22.18%
Earnings per share change (TTM)
21.56%
3-year revenue growth (CAGR)
16.25%
10-year revenue growth (CAGR)
15.45%
3-year earnings per share growth (CAGR)
26.07%
10-year earnings per share growth (CAGR)
16.72%
What the Analysts think about ISRG
Analyst ratings (Buy, Hold, Sell) for Intuitive Surgical stock.
Bulls say / Bears say
In Q3 2025, 204 of the 427 da Vinci systems placed were the next-generation da Vinci 5, more than doubling year-over-year and underscoring strong customer demand for the upgraded platform. (MarketBeat)
Worldwide procedures across the da Vinci and Ion platforms grew approximately 20% in Q3, including a 52% surge in Ion procedures, driving higher recurring revenue from instruments and accessories. (MarketBeat)
Management raised full-year 2025 worldwide da Vinci procedure growth guidance to 17%–17.5%, up from 15.5%–17%, reflecting confidence in sustained procedure adoption momentum. (Benzinga)
Government budget constraints in key overseas markets such as Japan and the U.K., combined with a highly competitive environment in China, have contributed to non-U.S. system utilization remaining about 20% below U.S. levels, potentially limiting international growth opportunities. (MarketBeat)
Intuitive lowered its full-year non-GAAP gross profit margin guidance to 66%–67% (from 69.1% in 2024) due to an estimated 1.0% revenue headwind from U.S. tariffs, signaling margin pressure ahead. (Intuitive Surgical)
The company plans to lay off up to 331 employees at its Sunnyvale production facility by October 2025, indicating operational cost pressures despite robust top-line performance. (San Francisco Chronicle)
Data summarised monthly by Lightyear AI. Last updated on 1 Nov 2025.
ISRG Financial Performance
Revenues and expenses
ISRG Earnings Performance
Company profitability
ISRG News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Intuitive Surgical stock?
Intuitive Surgical (ISRG) has a market cap of $189B as of November 03, 2025.
What is the P/E ratio for Intuitive Surgical stock?
The price to earnings (P/E) ratio for Intuitive Surgical (ISRG) stock is 70.69 as of November 03, 2025.
Does Intuitive Surgical stock pay dividends?
No, Intuitive Surgical (ISRG) stock does not pay dividends to its shareholders as of November 03, 2025.
When is the next Intuitive Surgical dividend payment date?
Intuitive Surgical (ISRG) stock does not pay dividends to its shareholders.
What is the beta indicator for Intuitive Surgical?
Intuitive Surgical (ISRG) has a beta rating of 1.61. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.